Infusion System Market Size Worth USD 29.45 Billion in 2032 | Emergen Research

The global infusion system market size was USD 14.90 billion in 2022 and is expected to register a rapid revenue CAGR of 7.1% during the forecast period. A recent market research report sheds light on the burgeoning growth of the global infusion system market, attributing it to a confluence of factors shaping the healthcare landscape. The report, which provides insights into market drivers, restraints, segment analysis, and end-use perspectives, indicates a promising trajectory for the market in the coming years.

Cancer Prevalence and Impact

Cancer prevalence remains a significant concern, particularly in India where an estimated 14,61,427 cases were reported in 2022, with lung and breast cancers being the most prevalent among males and females, respectively. The report forecasts a 12.8% increase in cancer cases by 2025 compared to 2020, underscoring the urgent need for effective healthcare solutions.

Get Free Sample Report and Related Graphs & Charts @ https://www.emergenresearch.com/request-sample/2745

Infusion System Market Drivers

The infusion system market is being propelled by several factors, including the increasing prevalence of cancer and chronic diseases, a growing demand for chemotherapy infusion systems, and advancements in technology. Home healthcare services are witnessing a surge in demand, further bolstering market growth alongside innovations in infusion system technologies, such as intelligent and wirelessly communicative systems.

Infusion System Market Restraints

However, the high cost of modern medical gadgets poses a significant barrier to market growth, especially in underdeveloped and developing countries. Healthcare institutions face financial hurdles due to the initial investment required for infusion devices and their upkeep, hindering widespread adoption.

Infusion System Market Segment Insights

The global infusion system market is segmented into various product categories, with the ambulatory infusion system segment emerging as the dominant player in 2022. Ambulatory systems, favored for their versatility in delivering nutrients and medications, accounted for the largest market share owing to the rising demand for enteral and syringe systems.

Infusion System Disease Indication Insights

In terms of disease indication, the report highlights steady growth in the pediatrics/neonatology segment, driven by rapid advancements in pediatric treatment and an increasing number of births globally. Intravenous infusion systems are extensively utilized in pediatric procedures, offering customizable and precise programmed delivery of fluids.

Get a Discount On The Purchase Of This Report @ https://www.emergenresearch.com/request-discount/2745

Infusion System End-Use Insights

Hospitals represent the primary end-use segment, expected to maintain a significantly large market share during the forecast period. The rising prevalence of chronic diseases, complex medical procedures, and an aging population contribute to the heightened demand for infusion systems in hospital settings. Technological advancements further enhance the usability, safety, and efficiency of infusion systems in various hospital departments.

Infusion System Top Companies and Competitive Landscape

The global infusion system market is fragmented, with large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective intrusion system products in the market.

Some of the major companies included in the global infusion system market report are:

• Braun SE
• Baxter
• Fresenius Kabi AG
• ICU Medical
• Smiths Group plc
• Terumo Corporation
• Pfizer Inc.
• Moog Inc.
• NIPRO
• com
• Medtronic
• Micrel Medical Devices SA
• Boston Scientific Corporation
• BD
• Hoffmann-La Roche Ltd.
• Tandem Diabetes Care, Inc.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Mindray)
• IRadimed Corporation

Infusion System Latest Industry News

• On 4 November 2021, ICU Medical, Inc. announced the acquisition of Pursuit Vascular, Inc., a medical device company that specializes in developing innovative products for the prevention of catheter-related bloodstream infections. This acquisition was aimed at enhancing ICU Medical's product offerings in the infusion system market.

• On 16 November 2020, B. Braun AG announced the acquisition of NxStage Medical, Inc., a medical device company that specializes in developing innovative products for the treatment of kidney failure.

Purchase This Market Research Report - https://www.emergenresearch.com/select-license/2745

Infusion System Market Segment Analysis

For the purpose of this report, Emergen Research has segmented the global infusion system market on the basis of product, disease indication, end-use, and region:

• Product Outlook (Revenue, USD Billion; 2019-2032)
o Volumetric Infusion System
o Syringe Infusion System
o Insulin Infusion System
o Enteral Infusion System
o Ambulatory Infusion System
o Patient-Controlled Analgesia Infusion System
o Implantable Infusion System
• Disease Indication Outlook (Revenue, USD Billion; 2019-2032)
o Chemotherapy Diabetes
o Gastroenterology
o Analgesia/Pain Management
o Pediatrics/Neonatology
o Others
• End-use Outlook (Revenue, USD Billion; 2019-2032)
o Hospitals
o Specialty Oncology Wards
o Homecare
• Regional Outlook (Revenue, USD Billion; 2019-2032)
o North America
1. U.S.
2. Canada
3. Mexico
o Europe
1. Germany
2. France
3. UK
4. Italy
5. Spain
6. Benelux
7. Rest of Europe
o Asia Pacific
1. China
2. India
3. Japan
4. South Korea
5. Rest of APAC
o Latin America
1. Brazil
2. Rest of LATAM
o Middle East & Africa
1. Saudi Arabia
2. UAE
3. South Africa
4. Turkey
5. Rest of Middle East & Africa

For more informative information, please visit us @ https://www.emergenresearch.com/industry-report/infusion-system-market

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.